Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins

Scandinavian Journal of Immunology

Volumn 65, Issue 3, 2007, Pages 230-239

  Dimitrov, J D ^a   Roumenina, L T ^b   Doltchinkova, V R ^b   Vassilev, T L ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ARTICLE; COMPLEMENT SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; MOLECULAR RECOGNITION; NEGATIVE FEEDBACK; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE INJURY;

COMPLEMENT ACTIVATION; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEME; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; IRON; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RHEUMATOID FACTOR;

EID: 33847058366     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01893.x     Document Type: Article

References (74)

1. Burton DR, Woof JM. Human antibody effector function. Adv Immunol 1992;51:1-84.
2. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 2000;18:709-37.
3. Walport MJ. Complement. N Engl J Med 2001;344:1058-66.
4. Walport MJ. Complement at the interface between the inate and adaptive immunity. N Engl J Med 2001;344:1140-4.
5. Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996;13:649-62.
6. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-82.
7. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest 1978;61:1161-7.
8. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann N Y Acad Sci 1988;524:103-21.
9. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
10. Biemond P, Swaak AJ, van Eijk HG, Koster JF. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Radic Biol Med 1988;4:185-98.
11. Brieland JK, Fantone JC. Ferrous iron release from transferrin by human neutrophil-derived superoxide anion: effect of pH and iron saturation. Arch Biochem Biophys 1991;284:78-83.
12. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417-27.
13. Aust SD. Ferritin as a source of iron and protection from iron-induced toxicities. Toxicol Lett 1995;82-83:941-4.
14. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002;32:568-76.
15. Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 1968;32:811-5.
16. Sears DA. Disposal of plasma heme in normal man and patients with intravascular hemolysis. J Clin Invest 1970;49:5-14.
17. Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 2005;157:175-88.
18. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
19. Welch KD, Davis TZ, Van Eden ME, Aust SD. Deleterious ironmediated oxidation of biomolecules. Free Radic Biol Med 2002;32:577-83.
20. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 2000;28:289-309.
21. Dimitrov JD, Ivanovska ND, Lacroix-Desmazes S, Doltchinkova VR, Kaveri SV, Vassilev TL. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J Biol Chem 2006;281:439-46.
22. Vassilev T, Yamamoto M, Aissaoui A et al. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol 1999;29:2436-42.
23. Debre M, Bonnet MC, Fridman WH et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993;342:945-9.
24. Keyer K, Imlay JA. Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci U S A 1996;93:13635-40.
25. Pourzand C, Watkin RD, Brown JE, Tyrrell RM. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci U S A 1999;96:6751-6.
26. Ramachandran A, Ceaser E, Darley-Usmar VM. Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins. Proc Natl Acad Sci U S A 2004;101:384-9.
27. Kishore U, Kojouharova MS, Reid KB. Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q. Immunobiology 2002;205:355-64.
28. Roumenina LT, Kantardjiev AA, Atanasov BP et al. Role of Ca(2+) in the Electrostatic Stability and the Functional Activity of the Globular Domain of Human C1q. Biochemistry 2005;44:14097-109.
29. Wines BD, Easterbrook-Smith SB. Carbodiimide crosslinking of human C1q and rabbit IgG. Mol Immunol 1990;27:221-6.
30. Suresh MV, Singh SK, Agrawal A. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem 2004;279:52552-7.
31. Roumenina LT, Rouseva M, Zlatarova A et al. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: a mutational analyses using recombinant globular regions of C1q A, B and C chains. Biochemistry 2006;45:4093-104.
32. Schafer FQ, Buettner GR. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic Biol Med 2000;28:1175-81.
33. Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology 2000;49:159-70.
34. del Zoppo GJ. In stroke, complement will get you nowhere. Nat Med 1999;5:995-6.
35. Baldwin WM III, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001;14:369-76.
36. Shen Y, Meri S. Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog Neurobiol 2003;70:463-72.
37. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431-56.
38. Hart ML, Walsh MC, Stahl GL. Initiation of complement activation following oxidative stress. In vitro and in vivo observations. Mol Immunol 2004;41:165-71.
39. Carroll MC, Michael Holers V, Innate autoimmunity. Adv Immunol 2006;86:137-57.
40. Roos A, Ramwadhdoebe TH, Nauta AJ, Hack CE, Daha MR. Therapeutic inhibition of the early phase of complement activation. Immunobiology 2002;205:595-609.
41. Pepys MB, Hirschfield GM, Tennent GA et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006;440:1217-21.
42. Camejo G, Halberg C, Manschik-Lundin A et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 1998;39:755-66.
43. Jeney V, Balla J, Yachie A et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002;100:879-87.
44. Grinshtein N, Bamm VV, Tsemakhovich VA, Shaklai N. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry 2003;42:6977-85.
45. Aft RL, Mueller GC. Hemin-mediated oxidative degradation of proteins. J Biol Chem 1984;259:301-5.
46. Vincent SH. Oxidative effects of heme and porphyrins on proteins and lipids. Semin Hematol 1989;26:105-13.
47. Miller YI, Felikman Y, Shaklai N. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys 1996;326:252-60.
48. Ziouzenkova O, Asatryan L, Akmal M et al. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999;274:18916-24.
49. Aft RL, Mueller GC. Hemin-mediated DNA strand scission. J Biol Chem 1983;258:12069-72.
50. Thomas DD, Espey MG, Vitek MP, Miranda KM, Wink DA. Protein nitration is mediated by heme and free metals through Fentontype chemistry: an alternative to the NO/O2- reaction. Proc Natl Acad Sci U S A 2002;99:12691-6.
51. Bian K, Gao Z, Weisbrodt N, Murad F. The nature of heme/iron-induced protein tyrosine nitration. Proc Natl Acad Sci U S A 2003;100:5712-7.
52. Wagener FA, Eggert A, Boerman OC et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001;98:1802-11.
53. Graca-Souza AV, Arruda MA, de Freitas MS, Barja-Fidalgo C, Oliveira PL. Neutrophil activation by heme: implications for inflammatory processes. Blood 2002;99:4160-5.
54. Wagener FA, Volk HD, Willis D et al. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003;55:551-71.
55. Arruda MA, Rossi AG, de Freitas MS, Barja-Fidalgo C, Graca-Souza AV. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol 2004;173:2023-30.
56. Kojouharova MS, Tsacheva I, Tchorbadjieva M, Reid KB, Kishore U. Localization of the ligand binding sites on the human C1q globular region using recombinant globular head fragments and single-chain antibodies. Biochim Biophys Acta 2003;1652:64-74.
57. Sutton B, Corper A, Bonagura V, Taussig M. The structure and origin of rheumatoid factors. Immunol Today 2000;21:177-83.
58. Newkirk MM. Rheumatoid factors: host resistance or autoimmunity? Clin Immunol 2002;104:1-13.
59. Renaudineau Y, Jamin C, Saraux A, Youinou P. Rheumatoid factor on a daily basis. Autoimmunity 2005;38:11-6.
60. Nowak UM, Newkirk MM. Rheumatoid factors: good or bad for you? Int Arch Allergy Immunol 2005;138:180-8.
61. Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA. Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci U S A 2000;97:10930-5.
62. Wentworth P Jr, McDunn JE, Wentworth AD et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002;298:2195-9.
63. Nieva J, Wentworth P. The antibody-catalyzed water oxidation pathway - a new chemical arm to immune defense? Trends Biochem Sci 2004;29:274-8.
64. Margiloff L, Chaplia L, Chow A, Singhal PC, Mattana J. Metal-catalyzed oxidation of immunoglobulin G impairs Fc receptor-mediated binding to macrophages. Free Radic Biol Med 1998;25:780-5.
65. Uesugi M, Yoshida K, Jasin HE. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 2000;165:6532-7.
66. Griffiths HR, Lunec J. The C1q binding activity of IgG is modified in vitro by reactive oxygen species: implications for rheumatoid arthritis. FEBS Lett 1996;388:161-4.
67. Griffiths HR, Lunec J. Effects of reactive oxygen species on immunoglobulin G function. Mol Aspects Med 1991;12:107-19.
68. Bobrovnik SA. Mechanisms for increasing the activity of polyreactive immunoglobulins in vivo. Ukr Biokhim Zh 1999;71:129-35.
69. McIntyre JA. The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation-reduction reactions. Thromb Res 2004;114:579-87.
70. McIntyre JA, Wagenknecht DR, Faulk WP. Autoantibodies unmasked by redox reactions. J Autoimmun 2005;24:311-7.
71. McIntyre JA, Wagenknecht DR, Faulk WP. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun Rev 2006;5:76-83.
72. Duke O, Panayi GS, Janossy G, Poulter LW. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 1982;49:22-30.
73. Young CL, Adamson TC III, Vaughan JH, Fox RI. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum 1984;27:32-9.
74. William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002;297:2066-72.